The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

Food and Drug Administration on Wednesday said it is aiming to reduce the number of human clinical studies required for ...

Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (=2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L treatment ...

Also, don’t miss Celebrate Autumn, Cherish Memories, Fight Alzheimer’s — Online Rally Nov. 6! on the Redmond Patch calendar ...

Loopworm’s Ankit Alok Bagaria explains why silkworm pupae could transform pet food as a sustainable, nutritious and scalable ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...

Novartis AG agreed to buy Avidity Biosciences Inc. in a $12 billion deal that’s the Swiss drugmaker’s biggest acquisition in ...

Licensing remains a dominant model. The value of the licensing-out deals signed by Chinese biotech firms in the first half of ...

A team of researchers from the University of Queensland are working to develop technology that could one day enable consumers ...